Stay updated on ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer
Sign up to get notified when there's something new on the ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer page.

Latest updates to the ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer page
- Check4 days agoChange DetectedThe location entry has been updated from Taoyuan District, Taiwan, 33305 to Taoyuan, Taiwan, 33305 in the Locations section. This clarifies the city designation for that site in the ATHENA study record.SummaryDifference0.0%

- Check11 days agoChange DetectedThe page shows a Revision tag updated to v3.5.3, indicating a software revision. The study details and visible content appear unchanged.SummaryDifference0.0%

- Check18 days agoChange DetectedThe page footer revision label was updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check40 days agoChange DetectedIn the Locations section, the Abbotsford entry is reformatted from 'Abbotsford, British Columbia, Canada, V2S 0C2' to 'Abbotsford British Columbia, British Columbia, Canada, V2S 0C2'.SummaryDifference0.0%

- Check47 days agoChange DetectedNapoli, Italy, 80131 was replaced with Naples, Italy, 80131 in the locations list. The revision tag was updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check54 days agoChange DetectedNo substantive content changes detected; the study’s core details remain the same.SummaryDifference0.0%

Stay in the know with updates to ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer
Enter your email address, and we'll notify you when there's something new on the ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer page.